Rothschild & Co Asset Management US’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $9.1M | Sell |
165,088
-27,167
| -14% | -$1.5M | 0.14% | 115 |
|
|
2022
Q3 | $8.52M | Sell |
192,255
-19,414
| -9% | -$860K | 0.15% | 117 |
|
|
2022
Q2 | $10.3M | Sell |
211,669
-5,068
| -2% | -$247K | 0.16% | 115 |
|
|
2022
Q1 | $10.5M | Sell |
216,737
-65,297
| -23% | -$3.18M | 0.13% | 132 |
|
|
2021
Q4 | $12M | Sell |
282,034
-17,985
| -6% | -$767K | 0.14% | 160 |
|
|
2021
Q3 | $11.5M | Buy |
+300,019
| New | +$11.5M | 0.14% | 167 |
|